Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Study ID: NCT06594991
Start Date: 2024-09-10
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

88

Intervention / Treatment

Familimab

Cemiplimab

Ipilimumab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Study ID: NCT06860594
Start Date: 2026-03-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Intensity-Modulated Radiation Therapy

Magnetic Resonance Imaging

Triapine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

Study ID: NCT00412594
Start Date: 2004-06-10
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Cladribine

Laboratory Biomarker Analysis

Rituximab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Study ID: NCT06077760
Start Date: 2023-12-06
End Date: 2035-12-21
Study Type

Interventional

Study Phase

Phase3

No. of Participants

868

Intervention / Treatment

Intismeran autogene

Pembrolizumab

Placebo

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Low Pressure Pneumo in RARP II

Study ID: NCT04394676
Start Date: 2020-08-04
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

Pressure applied during RARP

Sponsor

Metro Health, Michigan

Source: clinicaltrials.gov

Share:
Add to list

Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

Study ID: NCT06689176
Start Date: 2024-08-01
End Date: 2025-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Irrisept® Antimicrobial Wound Lavage

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Study ID: NCT04157127
Start Date: 2020-08-03
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Autologous DC Therapy

Sponsor

Diakonos Oncology Corporation

Source: clinicaltrials.gov

Share:
Add to list

177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma

Study ID: NCT06322576
Start Date: 2025-02-10
End Date: 2035-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

177Lu-PNT2002

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

Study ID: NCT03501576
Start Date: 2018-04-06
End Date: 2026-05-26
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Inactivated Influenza Vaccine

Sponsor

Emory University

Source: clinicaltrials.gov

Share:
Add to list

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Study ID: NCT04815876
Start Date: 2021-06-24
End Date: 2025-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1302

Intervention / Treatment

Transperineal MRI-guided prostate biopsy

Transrectal MRI-guided prostate biopsy

Antibiotic (prophylaxis)

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list